ExpreS2ion Biotech (Sweden) Analysis
| EXPRS2 Stock | SEK 21.60 0.80 3.57% |
ExpreS2ion Biotech Holding is overvalued with Real Value of 19.99 and Hype Value of 21.6. The main objective of ExpreS2ion Biotech stock analysis is to determine its intrinsic value, which is an estimate of what ExpreS2ion Biotech Holding is worth, separate from its market price. There are two main types of ExpreS2ion Biotech's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect ExpreS2ion Biotech's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of ExpreS2ion Biotech's stock to identify patterns and trends that may indicate its future price movements.
The ExpreS2ion Biotech stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ExpreS2ion Biotech's ongoing operational relationships across important fundamental and technical indicators.
ExpreS2ion |
ExpreS2ion Stock Analysis Notes
The book value of the company was currently reported as 2.75. The company recorded a loss per share of 1.55. ExpreS2ion Biotech had not issued any dividends in recent years. The entity had 40:1 split on the 30th of October 2024. ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology that enables the production of complex proteins for new vaccines and diagnostics of malaria. ExpreS2ion Biotech Holding AB is based in Horsholm, Denmark. ExpreS2ion Biotech operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 15 people. To learn more about ExpreS2ion Biotech Holding call the company at 45 22 22 10 19 or check out https://www.expres2ionbio.com.ExpreS2ion Biotech Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ExpreS2ion Biotech's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ExpreS2ion Biotech Holding or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| ExpreS2ion Biotech had very high historical volatility over the last 90 days | |
| The company reported the revenue of 12.23 M. Net Loss for the year was (43.92 M) with profit before overhead, payroll, taxes, and interest of 1.07 M. | |
| ExpreS2ion Biotech Holding has accumulated about 10.14 M in cash with (45.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. |
ExpreS2ion Biotech Thematic Classifications
In addition to having ExpreS2ion Biotech stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ITInformation technology and IT services |
ExpreS2ion Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 487.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ExpreS2ion Biotech's market, we take the total number of its shares issued and multiply it by ExpreS2ion Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 29th of March, ExpreS2ion Biotech shows the Downside Deviation of 3.18, coefficient of variation of 3798.48, and Mean Deviation of 2.88. ExpreS2ion Biotech technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.ExpreS2ion Biotech Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ExpreS2ion Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ExpreS2ion Biotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
ExpreS2ion Biotech Outstanding Bonds
ExpreS2ion Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ExpreS2ion Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ExpreS2ion bonds can be classified according to their maturity, which is the date when ExpreS2ion Biotech Holding has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
ExpreS2ion Biotech Predictive Daily Indicators
ExpreS2ion Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ExpreS2ion Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
ExpreS2ion Biotech Forecast Models
ExpreS2ion Biotech's time-series forecasting models are one of many ExpreS2ion Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ExpreS2ion Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About ExpreS2ion Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how ExpreS2ion Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ExpreS2ion shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ExpreS2ion Biotech. By using and applying ExpreS2ion Stock analysis, traders can create a robust methodology for identifying ExpreS2ion entry and exit points for their positions.
ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology that enables the production of complex proteins for new vaccines and diagnostics of malaria. ExpreS2ion Biotech Holding AB is based in Horsholm, Denmark. ExpreS2ion Biotech operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 15 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ExpreS2ion Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Complementary Tools for ExpreS2ion Stock analysis
When running ExpreS2ion Biotech's price analysis, check to measure ExpreS2ion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ExpreS2ion Biotech is operating at the current time. Most of ExpreS2ion Biotech's value examination focuses on studying past and present price action to predict the probability of ExpreS2ion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ExpreS2ion Biotech's price. Additionally, you may evaluate how the addition of ExpreS2ion Biotech to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |